Get started
Author

Afaaf Liberty

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial
2013 · Mark F Cotton, Avy Violari, et al. · The Lancet · 267
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
2019 · Avy Violari, Mark F. Cotton, et al. · Nature Communications · 103
PDF
Early severe HIV disease precedes early antiretroviral therapy in infants: Are we too late?
2014 · Steve Innes, Erica Lazarus, et al. · Journal of the International AIDS Society · 74
Efficacy and immunogenicity of influenza vaccine in HIV-infected children
2012 · Shabir A. Madhi, Sylvia Dittmer, et al. · AIDS · 41
Childhood adversity increases the risk of onward transmission from perinatal HIV-infected adolescents and youth in South Africa
2018 · Rachel Kidman, Sharon Nachman, et al. · Child Abuse & Neglect · 39
Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status
2016 · Pamela M. Murnane, Stacy-Lee Sigamoney, et al. · AIDS Care · 35
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
2022 · Pauline Amuge, Abbas Lugemwa, et al. · The Lancet HIV · 34
PDF
Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS
2022 · Sara Domínguez-Rodríguez, Miquel Serna-Pascual, et al. · PLoS ONE · 33
PDF
Distinct epigenetic profiles in children with perinatally-acquired HIV on antiretroviral therapy
2019 · Stephanie Shiau, Renate Strehlau, et al. · Scientific Reports · 32
PDF
Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study
2017 · Sarah M Ramteke, Stephanie Shiau, et al. · Journal of the Pediatric Infectious Diseases Society · 29
Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study
2018 · Helena Rabie, Paolo Denti, et al. · The Lancet HIV · 24
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
2022 · Anna Turkova, Hylke Waalewijn, et al. · The Lancet HIV · 23
PDF
Biomarkers of Aging in HIV-Infected Children on Suppressive Antiretroviral Therapy
2018 · Stephanie Shiau, Renate Strehlau, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 22
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide in adolescents and children with HIV: week 48 results of a single-arm, open-label, multicentre, phase 2/3 trial
2021 · Aditya H Gaur, Mark F Cotton, et al. · The Lancet Child & Adolescent Health · 21
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
2023 · Alexandra Compagnucci, Man K. Chan, et al. · EClinicalMedicine · 17
PDF
Virological outcomes and genotypic resistance on dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
2025 · Ellen White, Cissy Kityo, et al. · The Lancet HIV · 16
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study
2024 · Carina A Rodriguez, Eva Natukunda, et al. · The Lancet HIV · 14
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
2023 · Anna Turkova, Ellen White, et al. · The Lancet Child & Adolescent Health · 12
PDF
Recovery of HIV encephalopathy in perinatally infected children on antiretroviral therapy
2020 · Steve Innes, Barbara Laughton, et al. · Developmental Medicine & Child Neurology · 12
Experiences of South African caregivers disclosing to their children living with HIV: Qualitative investigations
2022 · Celeste Joyce, Candice Ramsammy, et al. · PLoS ONE · 11
PDF
Mitochondrial Impairment in Well-Suppressed Children with Perinatal HIV-Infection on Antiretroviral Therapy
2019 · Jing Shen, Afaaf Liberty, et al. · AIDS Research and Human Retroviruses · 11
The Etiology of Pneumonia in HIV-1-infected South African Children in the Era of Antiretroviral Treatment
2021 · David P. Moore, Vicky L. Baillie, et al. · The Pediatric Infectious Disease Journal · 10
Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral Therapy
2020 · Stephanie Shiau, Henry Evans, et al. · The Journal of Pediatrics · 8
Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir
2020 · Helena Rabie, Tjokosela Tikiso, et al. · Antimicrobial Agents and Chemotherapy · 8
Negative Diagnostic PCR Tests in School-Aged, HIV-Infected Children on Antiretroviral Therapy Since Early Life in Johannesburg, South Africa
2020 · Faeezah Patel, Cara Thurman, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 8
Works count: 53
Citation count: 1,018
H-index: 16
I10-index: 24
Year
Topic
Type